Table 3.
eGFR ≥90 mL/min/1.73m2 (n=1388) | eGFR <90 mL/min/1.73m2 (n=315) | P | eGFR ≥90 mL/min/1.73m2 (n=1388) | eGFR <90 mL/min/1.73m2 (n=315) | P | |
---|---|---|---|---|---|---|
Change in diastolic blood pressure, mmHg | Relative change in diastolic blood pressure, % | |||||
Placebo | −3.4 (−17.0, 10.3) | −1.4 (−17.8, 19.7) | 0.03 | −3.7 (−20.2, 15.9) | −0.7 (−20.8, 29.5) | 0.01 |
Low dose | −3.5 (−18.3, 10.0) | −5.9 (−27.3, 11.0) | 0.05 | −4.0 (−21.2, 14.7) | −6.4 (−28.6, 14.3) | 0.12 |
Medium dose | −5.1 (−20.3, 7.0) | −5.6 (−26.3, 16.0) | 0.68 | −6.3 (−24.1, 10.7) | −5.9 (−30.2, 27.4) | 0.81 |
High dose | −6.3 (−23.5, 10.0) | −16.1 (−30.0, −1.3) | <0.001 | −7.3 (−26.5, 12.5) | −18.4 (−34.6, −1.9) | <0.001 |
Change in systolic blood pressure, mmHg | Relative change in systolic blood pressure, % | |||||
Placebo | −5.8 (−23.7, 10.7) | −3.6 (−24.0, 21.0) | 0.05 | −4.2 (−16.9, 7.6) | −2.6 (−16.4, 17.0) | 0.05 |
Low dose | −6.3 (−24.0, 11.3) | −8.8 (−32.0, 9.7) | 0.09 | −4.6 (−17.2, 8.9) | −6.6 (−25.3, 8.4) | 0.06 |
Medium dose | −8.2 (−25.0, 6.7) | −8.4 (−31.0, 11.0) | 0.88 | −5.9 (−18.6, 5.4) | −6.4 (−24.0, 9.2) | 0.68 |
High dose | −10.4 (−28.3, 6.7) | −13.8 (−35.5, 0.0) | 0.05 | −7.7 (−21.2, 5.7) | −10.7 (−24.1, 0.0) | 0.02 |
Values are presented as mean (5, 95 percentiles).
eGFR indicates estimated glomerular filtration rate.